DJO Acquires MedShape, Inc.

DJO Acquires Trilliant Surgical

January 19, 2021

Medical Devices

DJO, LLC, a subsidiary of Colfax Corporation, has acquired Trilliant Surgical, a national provider of foot and ankle orthopedic implants and the maker of the Arsenal Foot Plating System. The acquisition expands DJO's reconstructive/foot & ankle product portfolio and capabilities as the company targets growth in the high-growth U.S. foot and ankle market.

EQT Private Equity Acquires 20% Stake in 3Shape

December 8, 2021

Medical Devices

EQT Private Equity (via the EQT IX fund) agreed to acquire a 20% minority stake in Copenhagen-based digital dentistry leader 3Shape from the company's founders, who remain majority shareholders. The investment will provide growth capital and access to EQT's digitalization and global healthcare expertise to accelerate 3Shape's international expansion and roll-out of additional digital services.

Medical Manufacturing Technologies (MMT) Acquires Innova Design, Inc.

August 25, 2025

Medical Devices

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, has acquired Innova Design, Inc., a pioneer in laser bonding equipment for catheter and interventional medical device manufacturing. The acquisition expands MMT’s bonding technology suite—adding Innova’s laser bonder platforms and related capabilities—to better serve medical device OEMs globally.

CONMED Corporation Acquires In2Bones Global, Inc.

June 13, 2022

Medical Devices

CONMED Corporation has completed its acquisition of privately-held In2Bones Global, Inc., a Memphis-based developer, manufacturer and distributor of medical devices for upper- and lower-extremity (hand, wrist, elbow, foot and ankle) care. The transaction was financed with proceeds from CONMED's convertible notes, borrowings under its amended credit facility and cash on hand.

Henry Schein Acquires Majority Interest in TriMed, Inc.

April 4, 2024

Medical Devices

Henry Schein, Inc. completed the acquisition of a majority interest in TriMed, Inc., a Santa Clarita, California–based developer of orthopedic implants and solutions for lower and upper extremities. TriMed reported approximately $52 million in 2023 net sales; the TriMed founders will remain with the business and financial terms were not disclosed. Henry Schein said the deal will broaden its surgical product offering to IDNs and ASCs and is expected to be neutral to 2024 non-GAAP EPS and accretive thereafter.

HealthEdge Investment Partners Invests in Anodyne

April 25, 2022

Medical Devices

HealthEdge Investment Partners completed a platform investment in Anodyne, a provider of lifestyle-oriented clinical footwear and custom orthotics most commonly prescribed for diabetic patients. HealthEdge will partner with Anodyne to accelerate growth, expand distribution and scale the company's in-house manufacturing capabilities.